• Title/Summary/Keyword: 심혈관 질환

Search Result 634, Processing Time 0.024 seconds

튼튼한 심장 ㆍ건강의 상징 (4)

  • KOREA ASSOCIATION OF HEALTH PROMOTION
    • 건강소식
    • /
    • v.16 no.7 s.164
    • /
    • pp.64-67
    • /
    • 1992
  • 각종 심장질환은 세계 사망원인의 1위를 차지하고 있다. 또한 선진국의 병으로만 생각했던 심장병이 여러가지 원인에 의해 이제는 개발도상국에서도 심각한 문제가 되었다. WHO는 이러한 추세에 따라 올해의 보건의 달 슬로건을 "튼튼한 심장, 건강의 상징(Hearetbeat-The Rhythm of Health)" 으로 정하고 "심장병 예방"에 대한 계몽에 나서고 있다. 본 글은, 심장질환 예방을 위한 프로그램등을 소개한 WHO의 자료를 번역한 것으로 약 4회에 걸쳐 게재된다.(편집자 주)

  • PDF

A Study of Serum Lipid, Blood Sugar, Blood Pressure of Buddhist Nuns in Vegetarians and Non-Vegetarians (III) - Based on Age - (채식인과 비채식 일반인의 혈중 지질, 혈당, 혈압에 관한 연구(III) -연령을 중심으로-)

  • Cha, Bok-Kyeong
    • Journal of the Korean Society of Food Science and Nutrition
    • /
    • v.33 no.8
    • /
    • pp.1311-1319
    • /
    • 2004
  • The purpose of this study was to compare the serum lipid level, blood sugar and blood pressure in vegetarians and non-vegetarians. The subjects of the study were 127 Buddhist nuns (age: 23∼79 y) from Oonmoon Temple in Choungdo district Gyeongsang Bookdo province and 118 Buddhist nuns practicing Zen meditation at Soodeok Temple in Yeosan district Chongcheong Namdo province. For control subjects, 235 healthy female adults (age: 23∼79 y) were selected. They were the nurses in the Gyeongsang National University Hospital, teachers and housekeepers living in Jinju, Gyeongsang Namdo province. The period of this study was from October 1996 to February 1997. The contents were consisted of food consumption survey, anthropometric measurement, estimated amount of energy expenditure, physical activity and clinical examination. The mean ages of the subjects were 44.2 y for vegetarians and 40.5 y for non-vegetarians, respectively. Average body mass index (BMI) of vegetarians and non-vegetarians were 22.47 and 21.08, WHR 0.85 and 0.84, percentage of body fat 28.79 and 26.55 respectively. The average duration of vegetarian diet of the vegetarians was 13.16 y. Levels of total cholesterol, LDL-cholesterol, atherogenic index (AI), diastolic blood pressure, blood sugar and HDL-cholesterol were significantly higher (p<0.01) in non-vegetarians than those of vegetarians. In both of subjects, levels of TG, total cholesterol, LDL-cholesterol, atherogenic index (AI) and systolic blood pressure were significantly higher (p<0.01) with an increment of age and the vegetarians showed a lower ratio of rise than the non-vegetarians. Levels of serum TG, LDL-cholesterol and AI were utmost in the 60 s and declined in the 70 s. Consequently, vegetarian diet can be considerably effective in reducing the level of the risk factors causing cardiovascular disease.

특집 예고 없이 찾아오는 심장질환, 생명을 위협한다! - 가면 쓴 살인자, 협심증.심근경색증 _운동 중 가슴 두근거림, 숨참, 흉통 느껴진다면

  • Gwak, Jeong-Eun
    • The Monthly Diabetes
    • /
    • s.256
    • /
    • pp.18-21
    • /
    • 2011
  • 당뇨병환자의 주된 사망 원인은 심장병이다. 당뇨병환자는 동맥경화증이 잘 생기고 이와 관련해 협심증, 심근경색증, 말초혈관질환, 뇌졸중이 잘 생기는 것으로 알려져 있다. 그중에서 관상동맥이 동맥경화증에 의해 막혀 생기는 대표적인 심혈관질환이 바로 협심증과 심근경색이다.

  • PDF

The Potential Therapeutic Effects of Endothelial Progenitor Cells in Ischemic Cardiovascular Disease (허혈성 심혈관 질환의 치료제로서 혈관내피전구세포(EPC)의 가능성에 대한 고찰)

  • Kim, Da Yeon;Kim, Bo Min;Kim, So Jung;Choi, Jin Hee;Kwon, Sang-Mo
    • Journal of Life Science
    • /
    • v.30 no.7
    • /
    • pp.651-659
    • /
    • 2020
  • Cardiovascular disease is one of the leading causes of death across the world, and gold-standard treatments such as percutaneous coronary intervention and artery bypass grafting have various limitations including myocardial damage and subsequent maladaptive cardiac remodeling. To overcome this, stem-cell therapies are emerging as a promising strategy for cardiovascular regeneration. Endothelial progenitor cells (EPCs) have high potential to proliferate and differentiate into endothelial cells for vascularization and tissue regeneration, and several clinical trials have explored EPC function in tissue repair in relation to clinical safety and improving cardiac function. Consequently, EPC has been suggested as a feasible stem-cell therapy. However, autologous EPC transplantation in cardiovascular disease patients is restricted by risk factors such as age, smoking status, and hypertension that lead to reduced bioactivity in the EPCs. New approaches for improving EPC function and stem-cell efficacy have therefore been suggested, including cell priming, organoid culture systems, and enhancing transplantation efficiency through 3D bioprinting methods. In this review, we provide a comprehensive understanding of EPC characteristics, therapeutic approaches, and the current state of clinical research into EPCs as stem-cell therapy for cardiovascular disease.